Dihexa vs Dihexa (Oral)
A side-by-side research comparison of Dihexa and Dihexa (Oral) across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Dihexa | Dihexa (Oral) |
|---|---|---|
| Full name | Dihexa (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide) | Dihexa (N-hexanoic-Tyr-Ile-(6) Aminohexanoic Amide) |
| Category | Cognitive & Nootropic | Cognitive & Nootropic |
| Status | Research compound | Research compound |
| Mechanism | Allosteric potentiator of HGF/c-Met signaling driving synaptogenesis, dendritic spine formation, and neuronal survival in hippocampal circuits. | Activates hepatocyte growth factor (HGF) / c-Met receptor system in the brain, triggering dendritic spine formation, synaptogenesis, and neuronal survival. This creates new neural pathways for learning and memory. |
| Molecular weight | 507.6 Da | 507.63 Da |
| Half-life | 6-12 hours | ~12 hours |
| Bioavailability | Moderate (oral/SubQ) | ~70% oral, ~60% intranasal |
| Typical dose | 10-20 mg (oral) or 2-5 mg (SubQ) | 10-20 mg |
| Frequency | Daily | Daily or every other day |
| Route | Oral or Subcutaneous | Oral capsule or sublingual |
Dihexa reported benefits
- Dramatic synaptogenesis
- Memory improvement
- Cognitive restoration potential
- Dendritic spine growth
- HGF/c-Met activation
Dihexa (Oral) reported benefits
- Synaptogenesis (new brain connections)
- Dramatic memory enhancement
- Learning acceleration
- Neuroprotection
- Cognitive recovery after injury
Related comparisons
Research and educational reference only. Not medical advice.